The accuracy was similar across the subgroups, with a similar percentage of results in Zone A and in Zones A and B of the ConEG (Table 2)—there were no statistically significant differences (at a 5% level) in accuracy detected (ANOVA) for diabetes type, insulin versus noninsulin users, trimester, age group, body mass index (BMI), or sensor lot. This evidence concerns the gene INS and diabetes mellitus.